Results 241 to 250 of about 83,610 (366)

Hemorrhagic Shock Due to Tubal Ectopic Pregnancy Following Curettage: A Case Report

open access: bronze
Ayşegül Akçebe   +4 more
openalex   +2 more sources

Can ratio of blood/curettage material HCG be used as a reliable method for differentiating miscarriage and ectopic pregnancy?

open access: gold, 2013
Gökhan Açmaz   +5 more
openalex   +1 more source

Prognostic Biomarker of Fertility‐Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer

open access: yesCancer Science, Volume 117, Issue 1, Page 236-245, January 2026.
We identified prognostic biomarkers that predict treatment outcomes in patients receiving fertility‐preserving high‐dose medroxyprogesterone acetate (MPA) therapy through comprehensive multigene panel testing. ABSTRACT In this study, we identified prognostic biomarkers that predict treatment outcome in patients receiving fertility‐preserving high‐dose ...
Takuro Hirano   +10 more
wiley   +1 more source

OC37.03: Routine use of ultrasound guided curettage for incomplete abortion or missed abortion—five years experience [PDF]

open access: bronze, 2005
L. Lopes   +5 more
openalex   +1 more source

Impact of Prolonged Surgical Waiting Time on 5‐Year Progression‐Free Survival in Patients With Endometrial Cancer

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 1, January 2026.
ABSTRACT Aim To evaluate the impact of surgical waiting time (SWT) on 5‐year progression‐free survival (PFS). Secondary objectives were to evaluate 5‐year overall survival (OS) and prognostic factors for recurrence and OS in endometrial cancer (EC), considering Thailand's Key Performance Indicator (KPI) recommending surgery within 4 weeks. Methods This
Ascharavadee Pulsawat   +2 more
wiley   +1 more source

Live Birth Outcomes After Extended or Repeated High‐Dose Medroxyprogesterone Acetate Therapy for Fertility‐Sparing Management of Endometrial Neoplasia: A Single‐Center Retrospective Case Series

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 1, January 2026.
ABSTRACT Aim To clarify live birth outcomes among women receiving extended or repeated high‐dose medroxyprogesterone acetate (MPA) therapy for fertility‐sparing management of atypical endometrial hyperplasia or endometrioid carcinoma grade 1. Methods We conducted a single‐center retrospective case series of 53 patients undergoing MPA therapy between ...
Akitoshi Yamamura   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy